Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04940585 · ClinicalTrials.gov registry record · NA
ROSE in Sunset Park
A NA study of Postpartum Depression, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 117
- Enrollment target
- 1
- Study location
NCT04940585: Recruiting NA study of Postpartum Depression, sponsored by NYU Langone Health.
NCT04940585 is a NA study of Postpartum Depression that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 117 participants, below the 473-participant average among 47 other Postpartum Depression trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04940585, a NA study of Postpartum Depression, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about pregnant women's' experience with Reach Out, Stay Strong, Essentials for mothers of newborns (ROSE) and to evaluate the effectiveness of the ROSE program in preventing and reducing post-partum depressive symptoms, decreasing stress, and increasing social support among pregnant women.
Primary Outcome
This will be measured by the client Satisfaction Questionnaire which is an 8-item questionnaire designed to assess the participant's satisfaction with a health service.
Conditions Studied
Interventions
- OTHER ROSE Program
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2021-03-21 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT04940585 shows while recruiting
NCT04940585 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 47 other Postpartum Depression trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 1 intervention - of which ROSE Program is the first listed.
NCT04940585 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04940585 about?
NCT04940585 is a clinical study titled "ROSE in Sunset Park". The purpose of this study is to learn more about pregnant women's' experience with Reach Out, Stay Strong, Essentials for mothers of newborns (ROSE) and to evaluate the effectiveness of the ROSE program in preventing and reducing post-partum depressive symptoms, decreasing stress, and increasing soc...
What is the current status of trial NCT04940585?
This trial is currently recruiting. It is a NA study. The enrollment target is 117 participants. The study started on 2021-03-21. Estimated completion is 2026-08-31.
What conditions does trial NCT04940585 study?
This clinical trial studies the following conditions: Postpartum Depression.
What interventions are being tested in trial NCT04940585?
The interventions under investigation include: ROSE Program (OTHER).
Who is sponsoring clinical trial NCT04940585?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04940585 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04940585's enrollment target sits among peer trials
117 23rd of 47 higher than 25 of 47 other Postpartum Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Postpartum Depression in Immigrant Latinas
RECRUITING · NA
-
In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
-
The Mom and Infant Outcomes (MOMI) Study
RECRUITING · NA
-
Maternal Stress on Human Milk and Infant Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT05277558 · 117 participants
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI